Search research articles
Contact Us
Filters
Showing results (1231-1240 of 1,291) with videos related to
Page
of 130
Sort By:
Scientific Reports
|
May 27, 2024
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy
Victor N Rivas, Amanda E Crofton, Carina E Jauregui, et al.
The Biochemical Journal
|
August 22, 2012
A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase
Hugh P Morgan, Martin J Walsh, Elizabeth A Blackburn, et al.
Kidney International
|
March 21, 2017
Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections
Jingjing Zhang, Ida M Friberg, Ann Kift-Morgan, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 12, 2005
Borna disease virus and mental health: a cross-sectional study
D Rh Thomas, R M Chalmers, B Crook, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2016
Highly selective inhibition of myosin motors provides the basis of potential therapeutic application
Serena Sirigu, James J Hartman, Vicente José Planelles-Herrero, et al.
Plos One
|
December 16, 2014
The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse
Andrew P Morgan, James J Crowley, Randal J Nonneman, et al.
Journal of the American Medical Informatics Association : JAMIA
|
April 21, 2016
Developing a digital data collection platform to measure the prevalence of sepsis in Wales
B Sharif, R M Lundin, P Morgan, et al.
Cell
|
October 24, 2017
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance
Stephan P Rosshart, Brian G Vassallo, Davide Angeletti, et al.
Journal of Medicinal Chemistry
|
February 21, 2003
In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist
Richard L Elliott, Robert M Oliver, Marlys Hammond, et al.
Thrombosis and Haemostasis
|
June 7, 2018
Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)
Wael Sumaya, William A E Parker, Rebekah Fretwell, et al.
Page
of 130
Search research articles
Search
Showing results (1231-1240 of 1,291) with videos related to
Sort By:
Page
of 130
Scientific Reports
|
May 27, 2024
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy
Victor N Rivas, Amanda E Crofton, Carina E Jauregui, et al.
The Biochemical Journal
|
August 22, 2012
A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase
Hugh P Morgan, Martin J Walsh, Elizabeth A Blackburn, et al.
Kidney International
|
March 21, 2017
Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections
Jingjing Zhang, Ida M Friberg, Ann Kift-Morgan, et al.
QJM : Monthly Journal of the Association of Physicians
|
March 12, 2005
Borna disease virus and mental health: a cross-sectional study
D Rh Thomas, R M Chalmers, B Crook, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2016
Highly selective inhibition of myosin motors provides the basis of potential therapeutic application
Serena Sirigu, James J Hartman, Vicente José Planelles-Herrero, et al.
Plos One
|
December 16, 2014
The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse
Andrew P Morgan, James J Crowley, Randal J Nonneman, et al.
Journal of the American Medical Informatics Association : JAMIA
|
April 21, 2016
Developing a digital data collection platform to measure the prevalence of sepsis in Wales
B Sharif, R M Lundin, P Morgan, et al.
Cell
|
October 24, 2017
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance
Stephan P Rosshart, Brian G Vassallo, Davide Angeletti, et al.
Journal of Medicinal Chemistry
|
February 21, 2003
In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist
Richard L Elliott, Robert M Oliver, Marlys Hammond, et al.
Thrombosis and Haemostasis
|
June 7, 2018
Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study)
Wael Sumaya, William A E Parker, Rebekah Fretwell, et al.
Page
of 130